Events

BIO–Europe is held annually in different cities and is an international forum to promote business development between pharmaceutical, financial and biotechnology companies. The event is Europe’s largest partnering conference serving the global biotech industry.

This is the 69th annual meeting of Korean Pain Society (KPS). The organization has grown into a community of more than 4,800 participating members. KPS plays an important role in Korea in in the domains of education, treatment and research in the field of pain medicine.

The conference introduces growth-stage companies (Resource, Technology, Biotech, Special Situations) to active top-level capital finance individuals through a day of scheduled one-on-one meetings.

Dr John L. Wallace, our Chief Scientific Officer, will deliver a Keynote Lecture at The Sergio H. Ferreira Conference, named for the researcher whose work led to the development of ACE inhibitors—a widely used class of drugs for cardiovascular disease. The lecture is entitled “A Gas From The Past: Safer, More Effective Anti-inflammatory Drugs”.

Dr. John L. Wallace, Antibe’s Chief Scientific Officer, will deliver a lecture entitled: “Toward Safer and Effective Analgesics: Clinical Trials of an H2S-releasing NSAID for Osteoarthritis” at the flagship annual meeting of the British Pharmacological Society. The programme covers the full range of pharmacological specialties, involving clinical and non-clinical domains in academia and industry.

Biotech Showcase allows companies to build their profile with investors and strategic partners. In addition, presenters conduct one-to-one meetings and participate in informal networking.

The conference introduces growth-stage companies (Non-Resource, Technology, Biotech, Special Situations) to active top-level capital finance individuals through a day of scheduled one-on-one meetings.

Bloom Burton’s annual Healthcare Investor Conference will host many of Canada’s premier publicly traded, venture-backed and pre-venture private companies. The event attracts Canadian, US and international investors. Investors have the opportunity to obtain corporate updates from presenting companies, and participate in their one-on-one meeting system with company management.